Glenn Agre Bergman & Fuentes Expands Structured Financial Products Litigation Practice with Fourth Attorney This Year

Glenn Agre Bergman & Fuentes hired Christopher P. Johnson as a New York partner, its fourth structured-finance litigation addition in 2026, following the June arrival of Zachary Mazin and two colleagues from McKool Smith. The firm is expanding around expected disputes in the multi-trillion-dollar private-credit market, citing weaker disclosure and potential asset-quality, collateral and insolvency conflicts. The announcement is primarily a law-firm personnel expansion, though it highlights rising concern over litigation risks in private-credit and securitized-finance structures.

Analysis

This is not a fundamental catalyst for FNMA or FMCC; the firms remain driven by conservatorship policy, capital-rule outcomes and housing-credit performance rather than a law-firm hiring announcement. The useful signal is qualitative: specialist capacity is being assembled around opaque structured-credit disputes, which can increase the probability that distressed-credit investors and trustees pursue claims once collateral losses expose documentation, valuation or priority defects.

Near term, no read-through to the GSE common shares is warranted. Over the next 1-3 months, monitor private-credit stress indicators—BDC non-accruals, leveraged-loan defaults, warehouse-facility amendments and CLO equity cash-flow diversions—for confirmation that litigation is becoming an investable cost rather than a promotional narrative. The most exposed public vehicles would likely be externally managed BDCs and alternative asset managers with sizable originated-credit, asset-backed lending or NAV-financing businesses, rather than agency-MBS guarantors.

The contrarian point is that rising litigation risk can be a secondary beneficiary for well-capitalized alternative managers: forced asset sales and lender retrenchment widen origination spreads for firms with permanent capital. Conversely, a benign default cycle would leave this development economically irrelevant; legal teams can be hired well ahead of any realizable claims, and recoveries typically arrive years after underlying credit impairment.

Key Decisions for Investors

• No directional trade in FNMA or FMCC on this item; retain existing exposure only against identifiable conservatorship or capital-policy catalysts, not structured-finance litigation expectations.
• Create a 1-3 month monitoring basket of BDCs with elevated non-accrual, PIK-income or NAV-financing sensitivity—ARCC, OCSL, FSK, BXSL—and flag any quarterly increase in non-accruals above 50 bps of fair value or material realized-loss guidance.
• If credit stress confirms through widening leveraged-loan spreads and rising BDC non-accruals, consider a defensive pair: long ARCC versus short FSK for 3-6 months. ARCC's scale and sponsor relationships should provide better workout capacity; exit if FSK's non-accrual ratio stabilizes or ARCC's NAV declines materially faster.
• Watch listed alternative managers KKR, ARES and BX for disclosure on private-credit marks, warehouse leverage and insurance/structured-credit exposure. A broad litigation narrative alone is insufficient for a short; require evidence of NAV markdowns, covenant amendments or asset-specific impairment before acting.